(Q66395847)

English

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

clinical trial

In more languages

Statements

0 references

A Phase II Study of Apatinib In Combination With Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer (English)

0 references

10 August 2016

0 references

31 December 2017

0 references

number of participants

35

0 references

research intervention

etoposide phosphate

0 references

clinical trial phase

phase II clinical trial

0 references

18 year

0 references

70 year

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q66395847&oldid=1858866655"